Results 101 to 110 of about 51,654 (292)
Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%.
Denise Oliveira Pellegrini+9 more
doaj +1 more source
We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core +1 more source
Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance [PDF]
Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention.
Bavry+15 more
core +2 more sources
ABSTRACT This study aims to investigate the relationship between serum secreted frizzled‐related protein 5 (SFRP5), apolipoprotein A‐I (ApoA‐I), high‐density lipoprotein 3‐cholesterol (HDL3‐C) and in‐stent restenosis (ISR) after percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) and their combined predictive value.
Li‐Qiang Cui, Xue‐Dong Wang
wiley +1 more source
Drug-eluting coronary stents – focus on improved patient outcomes
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj
Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents [PDF]
Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in
Fajadet+18 more
core +2 more sources
Polymer-based or polymer-free stents in patients at high bleeding risk [PDF]
Background: polymer-free drug-coated stents provide superior clinical outcomes to bare-metal stents in patients at high bleeding risk who undergo percutaneous coronary intervention (PCI) and are treated with 1 month of dual antiplatelet therapy.
Abdul Ghapar, Kahar Bin+32 more
core +2 more sources
Electrospun nanofibers provide a unique platform for photosensitizers, due to their large surface area and biocompatibility, improving both loading efficiency and controlled release. The photosensitizer‐modified nanofibers are activated upon light exposure, and produce reactive oxygen species to treat cancer, pathogen infections, and wounds.
Aslı Eldem+3 more
wiley +1 more source
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M+6 more
core +2 more sources
Hemodynamics of Stent Implantation Procedures in Coronary Bifurcations: an in vitro study [PDF]
Stent implantation in coronary bifurcations presents unique challenges and currently there is no universally accepted stent deployment approach. Despite clinical and computational studies, to date, the effect of each stent implantation method on the coronary artery hemodynamics is not well understood.
arxiv